Kanamycin is an aminoglycoside antibiotic used in the manufacture of pharmaceutical products for treating severe bacterial infections, including tuberculosis, when administered by injection or orally. It is not a first-line treatment.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 59-01-8
Canamycin A disulfate
pharmaceutical raw material
Kanamycin A sulfate
pharmaceutical raw material
Kanamycin sulfate
pharmaceutical raw material
Tobramycin sulfate
pharmaceutical raw material
Tobramycin
pharmaceutical raw material
Methotrexate
pharmaceutical raw material
Ethopabate
pharmaceutical raw material
Nikethamide
pharmaceutical raw material
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol
SBUJHOSQTJFQJX-NOAMYHISSA-N
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N